24 research outputs found
sj-docx-1-nah-10.1177_02601060221136918 - Supplemental material for A high-protein peptide-based enteral formula improves diarrhea in tube-fed patients: A prospective multicenter study
No full textSupplemental material, sj-docx-1-nah-10.1177_02601060221136918 for A high-protein peptide-based enteral formula improves diarrhea in tube-fed patients: A prospective multicenter study by Sornwichate Rattanachaiwong, Tippawan Siritientong, Veeradej Pisprasert, Pranithi Hongsprabhas, Phitphiboon Deawtrakulchai, Somkit Williams, Naluttaporn Suebsoh, Sidarut Samuksaman, Phayom Bunsut, Pornpoj Pramyothin, Nanta Khumkhana, Pennapa Tipsung, Mayura Vattanapongpisan and Panuwat Promsin in Nutrition and Health</p
Additional file 1 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 1. Complete documentation of formulas used for mathematical modelling of data
Additional file 1 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 1. Complete documentation of formulas used for mathematical modelling of data
Additional file 3 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 3. Individual values for lactate concentrations in plasma for healthy volunteers and ICU patients during experiment
Additional file 2 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 2. Plasma lactate enrichment of labeled lactate for healthy volunteers and ICU patient
Additional file 2 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 2. Plasma lactate enrichment of labeled lactate for healthy volunteers and ICU patient
Additional file 3 of Lactate kinetics in ICU patients using a bolus of 13C-labeled lactate
No full textAdditional file 3. Individual values for lactate concentrations in plasma for healthy volunteers and ICU patients during experiment
The incidence, characteristics, impact and risk factors of post-COVID chronic pain in Thailand: a single-center cross-sectional study
Get PDFThe COVID-19 pandemic has affected millions of individuals worldwide. Pain has emerged as a significant post-COVID-19 symptom. This study investigated the incidence, characteristics, and risk factors of post-COVID chronic pain (PCCP) in Thailand. A cross-sectional study was conducted in participants who had been infected, including those hospitalized and monitored at home by SARS-CoV-2 from August to September 2021. Data were collected for screening from medical records, and phone interviews were done between 3 to 6 months post-infection. Participants were classified into 1) no-pain, 2) PCCP, 3) chronic pain that has been aggravated by COVID-19, or 4) chronic pain that has not been aggravated by COVID-19. Pain interference and quality of life were evaluated with the Brief Pain Inventory and EuroQol Five Dimensions Five Levels Questionnaire. From 1,019 participants, 90% of the participants had mild infection, assessed by WHO progression scale. The overall incidence of PCCP was 3.2% (95% CI 2.3–4.5), with 2.8% (95% CI 2.0–4.1) in mild infection, 5.2% (95% CI 1.2–14.1) in moderate infection and 8.5% (95% CI 3.4–19.9) in severe infection. Most participants (83.3%) reported pain in the back and lower extremities and were classified as musculoskeletal pain and headache (8.3%). Risk factors associated with PCCP, included female sex (relative risk [RR] 2.2, 95% CI 1.0–4.9) and greater COVID-19 severity (RR 3.5, 95% CI 1.1–11.7). Participants with COVID-19-related exacerbated chronic pain displayed higher pain interferences and lower utility scores than other groups. In conclusion, this study highlights the incidence, features, and risk factors of post-COVID chronic pain (PCCP) in Thailand. It emphasizes the need to monitor and address PCCP, especially in severe cases, among females, and individuals with a history of chronic pain to improve their quality of life in the context of the ongoing COVID-19 pandemic
Interview script and questionaire.
No full textThe COVID-19 pandemic has affected millions of individuals worldwide. Pain has emerged as a significant post-COVID-19 symptom. This study investigated the incidence, characteristics, and risk factors of post-COVID chronic pain (PCCP) in Thailand. A cross-sectional study was conducted in participants who had been infected, including those hospitalized and monitored at home by SARS-CoV-2 from August to September 2021. Data were collected for screening from medical records, and phone interviews were done between 3 to 6 months post-infection. Participants were classified into 1) no-pain, 2) PCCP, 3) chronic pain that has been aggravated by COVID-19, or 4) chronic pain that has not been aggravated by COVID-19. Pain interference and quality of life were evaluated with the Brief Pain Inventory and EuroQol Five Dimensions Five Levels Questionnaire. From 1,019 participants, 90% of the participants had mild infection, assessed by WHO progression scale. The overall incidence of PCCP was 3.2% (95% CI 2.3–4.5), with 2.8% (95% CI 2.0–4.1) in mild infection, 5.2% (95% CI 1.2–14.1) in moderate infection and 8.5% (95% CI 3.4–19.9) in severe infection. Most participants (83.3%) reported pain in the back and lower extremities and were classified as musculoskeletal pain and headache (8.3%). Risk factors associated with PCCP, included female sex (relative risk [RR] 2.2, 95% CI 1.0–4.9) and greater COVID-19 severity (RR 3.5, 95% CI 1.1–11.7). Participants with COVID-19-related exacerbated chronic pain displayed higher pain interferences and lower utility scores than other groups. In conclusion, this study highlights the incidence, features, and risk factors of post-COVID chronic pain (PCCP) in Thailand. It emphasizes the need to monitor and address PCCP, especially in severe cases, among females, and individuals with a history of chronic pain to improve their quality of life in the context of the ongoing COVID-19 pandemic.</div
